Firms
Conviction Partners
- Founded
- —
- Type
- Venture capital
Team
No team members on record yet.
Co-investing
Y Combinator
Latent Health$80M · 2026-04-08
Latent Health$— · 2026-03-18
Latent Health$80M · 2026-03-18
Onyx$113M · 2026
Sola$17M · 2025-08-26
Design Arena$7M · Unknown date
Latent$80M · Unknown date
General Catalyst
Latent Health$80M · 2026-04-08
Latent Health$— · 2026-03-18
Latent Health$80M · 2026-03-18
Tahoe Therapeutics$30M · 2025
Mistral$— · 2023-12-11
Latent$80M · Unknown date
McKesson Ventures
Latent Health$80M · 2026-04-08
Latent Health$— · 2026-03-18
Latent Health$80M · 2026-03-18
Latent$80M · Unknown date
Spark Capital
Latent Health$80M · 2026-04-08
Latent Health$— · 2026-03-18
Latent Health$80M · 2026-03-18
Latent$80M · Unknown date
Transformation Capital
Latent Health$80M · 2026-04-08
Latent Health$— · 2026-03-18
Latent Health$80M · 2026-03-18
Latent$80M · Unknown date
Sequoia
Rowspace$50M · 2026-02-25
Listen Labs$69M · 2026-01-14
Harvey$160M · 2025-12-04
A*
Design Arena$7M · Unknown date
Amplify Partners
Tahoe Therapeutics$30M · 2025
Anthology Fund
RunSybil$40M · 2026-03-18
Basis Set Ventures
Rowspace$50M · 2026-02-25
Ben's Bites
Pika Labs$55M · 2023
BNP Paribas
Mistral$— · 2023-12-11
CIV
Tahoe Therapeutics$30M · 2025
Civilization Ventures
Tahoe Therapeutics$30M · 2025
Conviction
Latent Health$80M · 2026-03-18
Cyberstarts
Onyx$113M · 2026
Darian Shirazi
Rowspace$50M · 2026-02-25
Databricks Ventures
Tahoe Therapeutics$30M · 2025
Emergence Capital
Rowspace$50M · 2026-02-25
EQT Ventures
Harvey$160M · 2025-12-04
Evantic
Listen Labs$69M · 2026-01-14
Fin Capital
Sola$17M · 2025-08-26
Index Ventures
Design Arena$7M · Unknown date
JAM FINTOP
Sola$17M · 2025-08-26
Kleiner Perkins
Harvey$160M · 2025-12-04
Notion Capital
Pika$55M · 2023-11-28
Pear VC
Listen Labs$69M · 2026-01-14
QuantumLight
Onyx$113M · 2026
Ribbit Capital
Listen Labs$69M · 2026-01-14
Salesforce Ventures
Mistral$— · 2023-12-11
Twine Ventures
Rowspace$50M · 2026-02-25
Vinod Khosla
RunSybil$40M · 2026-03-18
Wing Venture Capital
Tahoe Therapeutics$30M · 2025




